|
Name |
16-hydroxy-virginiamycin M1
|
Molecular Formula | C28H37N3O7 | |
IUPAC Name* |
21,23-dihydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14-trione
|
|
SMILES |
CC1=CC(O)CC(O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)OC(C(C)C)C(C)C=CC(=O)NCC=C1
|
|
InChI |
InChI=1S/C28H37N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-21,26,32-33H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,21-,26-/m1/s1
|
|
InChIKey |
POYSSLVLYAFLLJ-SOXVDNTRSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 527.62 | ALogp: | 2.5 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 142.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 38 | QED Weighted: | 0.473 |
Caco-2 Permeability: | -5.206 | MDCK Permeability: | 0.00001340 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.683 |
Human Intestinal Absorption (HIA): | 0.537 | 20% Bioavailability (F20%): | 0.19 |
30% Bioavailability (F30%): | 0.496 |
Blood-Brain-Barrier Penetration (BBB): | 0.699 | Plasma Protein Binding (PPB): | 68.04% |
Volume Distribution (VD): | 1.273 | Fu: | 21.57% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.06 |
CYP2C19-inhibitor: | 0.044 | CYP2C19-substrate: | 0.069 |
CYP2C9-inhibitor: | 0.191 | CYP2C9-substrate: | 0.12 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.251 |
CYP3A4-inhibitor: | 0.37 | CYP3A4-substrate: | 0.363 |
Clearance (CL): | 7.087 | Half-life (T1/2): | 0.856 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.379 |
Drug-inuced Liver Injury (DILI): | 0.37 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.137 | Maximum Recommended Daily Dose: | 0.957 |
Skin Sensitization: | 0.194 | Carcinogencity: | 0.918 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.852 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003558 | 0.826 | D05AFC | 0.532 | ||||
ENC005287 | 0.825 | D05MNW | 0.345 | ||||
ENC002429 | 0.641 | D07XGH | 0.345 | ||||
ENC005087 | 0.288 | D06WTZ | 0.233 | ||||
ENC003855 | 0.256 | D0L7LC | 0.223 | ||||
ENC002049 | 0.252 | D00TLP | 0.220 | ||||
ENC003672 | 0.248 | D03LJR | 0.216 | ||||
ENC002121 | 0.246 | D0H0ND | 0.214 | ||||
ENC000662 | 0.245 | D09NNH | 0.214 | ||||
ENC001855 | 0.245 | D06YFA | 0.211 |